Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease

Handb Clin Neurol. 2022:184:153-166. doi: 10.1016/B978-0-12-819410-2.00008-4.

Abstract

Alpha-synuclein (α-synuclein) is a small, acidic protein containing 140 amino acids, highly expressed in the brain and primarily localized in the presynaptic terminals. It is found in high concentrations in Lewy Bodies, proteinaceous aggregates that constitute a typical histopathologic hallmark of Parkinson's disease. Altered environmental conditions, genetic mutations and post-translational changes can trigger abnormal aggregation processes with the increased frequency of oligomers, protofibrils, and fibrils formation that perturbs the neuronal homeostasis leading to cell death. Relevant to neuronal activity, a function of α-synuclein that has been extensively detailed is its regulatory actions in the trafficking of synaptic vesicles, including the processes of exocytosis, endocytosis and neurotransmitter release. Most recently, increasing attention has been paid to the possible role that α-synuclein plays at a postsynaptic level by interacting with selective subunits of the glutamate N-methyl-d-aspartate receptor, altering the corticostriatal plasticity of distinct neuronal populations.

Keywords: Dopamine; Experimental parkinsonism; Nucleus striatum; Synaptic plasticity; Synucleinopathies.

Publication types

  • Review

MeSH terms

  • Animals
  • Corpus Striatum
  • Disease Models, Animal
  • Humans
  • Lewy Bodies
  • Models, Animal
  • Parkinson Disease* / genetics
  • alpha-Synuclein* / genetics
  • alpha-Synuclein* / metabolism

Substances

  • alpha-Synuclein